REGENXBIO Inc.

RGNX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001590877

SEC filings (opens in a new tab)

In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 1 sale; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding REGENXBIO Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of RGNX: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	172	2	183	+13
Shares	33.5M	8.24K	33.4M	−84.6K (−0.3%)
Value	$1.30B	$321.0K	$1.40B	+$100.0M (+7.7%)

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held REGENXBIO Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to RGNX in Q3 2021
Institution	Shares	Value	% of portfolio
Assenagon Asset Management S.A.	137,753	$5.78M	0.02%
Voloridge Investment Management, LLC	88,404	$3.71M	0.02%
Connor, Clark & Lunn Investment Management Ltd.	77,182	$3.23M	0.02%
Integral Health Asset Management, LLC	55,000	$2.31M	0.66%
SG Americas Securities, LLC	33,719	$1.41M	0.01%
Jump Financial, LLC	15,073	$632.0K	0.05%
Maryland State Retirement & Pension System	14,751	$623.0K	0.02%
Walleye Capital LLC	12,782	$536.0K	0.02%
Winton Group Ltd	11,986	$502.0K	0.03%
Franklin Resources Inc	10,402	$436.0K	0.00%
Skandinaviska Enskilda Banken AB (publ)	7,600	$319.0K	0.00%
Marshall Wace North America L.P.	7,200	$301.0K	0.00%
Envestnet Asset Management Inc	6,934	$291.0K	0.00%
Gsa Capital Partners LLP	6,825	$286.0K	0.03%
Quantbot Technologies LP	5,729	$240.0K	0.02%
Teacher Retirement System of Texas	5,135	$215.0K	0.00%
Everence Capital Management Inc	5,140	$215.0K	0.02%
Crawford Lake Capital Management, LLC	5,000	$210.0K	0.14%
Caption Management, LLC	5,000	$210.0K	0.01%
Victory Capital Management Inc	4,794	$201.0K	0.00%
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna	4,000	$167.7K	0.04%
Koshinski Asset Management, Inc.	600	$25.2K	0.00%
Federation des caisses Desjardins du Quebec	200	$8.38K	0.00%
JFS Wealth Advisors, LLC	80	$3.00K	0.00%
Fifth Third Bancorp	58	$2.00K	0.00%
Private Capital Group, LLC	14	$1.00K	0.00%
Quadrant Capital Group LLC	8	$0	0.00%
Berman Capital Advisors, LLC	14	$0	0.00%
Meridian Wealth Partners, LLC	3	$0	0.00%

Sold out (16)

Institutions that held REGENXBIO Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of RGNX in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Jacobs Levy Equity Management, Inc	179,521	$6.97M
Point72 Asset Management, L.P.	163,608	$6.36M
Altium Capital Management LP	62,317	$2.42M
PDT Partners, LLC	50,331	$1.96M
Tekla Capital Management LLC	21,700	$843.0K
Blueshift Asset Management, LLC	11,342	$441.0K
HSBC Holdings PLC	7,788	$308.0K
Ergoteles LLC	7,400	$287.0K
Gyon Technologies Capital Management, LP	6,257	$243.0K
Virginia Retirement Systems Et Al	6,100	$237.0K
Vident Investment Advisory, LLC	5,482	$213.0K
Guggenheim Capital LLC	5,419	$211.0K
Towarzystwo Funduszy Inwestycyjnych Pzu SA	3,900	$151.5K
FORA Capital, LLC	3,539	$137.0K
Point72 Hong Kong Ltd	1,890	$73.0K
Tarbox Family Office, Inc.	1,000	$39.0K

Not filed for Q3 2021 yet (2)

Institutions that held REGENXBIO Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RGNX in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
QS Investors, LLC	8,200	$319.0K
Smith Asset Management Group LP	40	$2.00K